what happens when you eat sugar on semaglutide Semaglutide: The Game Changer in Medical Weight Loss Semaglutide GLP-1 Treatment Specialist |

In clinical trials, people lost an average of 17% of their body weight over 64 weeks, with around one in four losing 20% or more

For type 2 diabetes management , NICE guidance (NG28) recommends GLP-1 agonists as second- or third-line therapy when metformin and other oral agents provide inadequate glycaemic control, or as an alternative to insulin in appropriate patients

Track your energy levels daily on a scale of 1 to 10, and note functional improvements

Phase 2 Obesity Trial Jastreboff et al., New England Journal of Medicine (2023) Jastreboff and colleagues conducted a phase 2, double-blind, randomized, placebo-controlled trial of retatrutide in adults with obesity